scholarly journals Chronobiological Factors Related to Sleep and Neuropsychiatric Symptoms in Persons Living With Dementia

2021 ◽  
Vol 5 (Supplement_1) ◽  
pp. 436-437
Author(s):  
Nancy Hodgson ◽  
Fanghong Dong
Keyword(s):  
Circadian Rhythm ◽  
White Light ◽  
Salivary Cortisol ◽  
Light Exposure ◽  
Neuropsychiatric Symptoms ◽  
Clear Understanding ◽  
Diurnal Cortisol ◽  
Endogenous Factors ◽  
Subjective Sleep ◽  
Rhythm Pattern

Abstract Circadian rhythm disturbances (CRD) are commonly seen in people living with dementia. A clear understanding of the role of CRD in dementia etiology will be beneficial by exploring the exogenous factors (externally influence the duration of sleep hours, such as light/dark cycles) and endogenous factors (internal biological rhythm, such as diurnal cortisol pattern). This symposium will apply a chronobiological approach to study exogenous and endogenous factors that influence circadian rhythm and their effects on sleep and neuropsychiatric symptoms in persons living with dementia (PLWD). Four paper presentations will use secondary data analysis of data from the Healthy Patterns Clinical Trial (NCT03682185), a randomized controlled trial of a home-based activity intervention designed to improve circadian rhythm disorders in PLWD. We will first describe the circadian rhythm pattern reflected by endogenous factors (salivary cortisol), then examine salivary cortisol (endogenous) and white light intensity (exogenous) and on subjective sleep and neuropsychiatric symptoms (including depression) in PLWD, respectively. In session 1, we will present cortisol diurnal rhythm pattern in PLWD using a cross-sectional design. In session 2, we will discuss the relationship between salivary cortisol indicators and depressive symptoms. In session 3, we focus on the association between diurnal cortisol slope and neuropsychiatric symptoms using the baseline data. In session 4, we describe the association between evening white light exposure and subjective sleep. The discussant will describe how these findings build on our understanding the nature of circadian rhythm disturbance in dementia and inform future research and treatment approaches.

Abstract P160: Non-invasive Method to Assess Human Circadian Rhythms

Hypertension ◽  
2016 ◽  
Vol 68 (suppl_1) ◽  
Author(s):  
Daian Chen ◽  
S Justin Thomas ◽  
David A Calhoun ◽  
David M Pollock ◽  
Jennifer S Pollock
Keyword(s):  
Circadian Rhythm ◽  
Circadian Rhythms ◽  
Salivary Cortisol ◽  
Metabolic Diseases ◽  
Clock Genes ◽  
Light Exposure ◽  
Rna Isolation ◽  
Buccal Cells ◽  
Non Invasive ◽  
Salivary Melatonin

Circadian rhythms are controlled by an endogenous time-keeping system oscillating approximately on a 24-h cycle under constant conditions. These rhythms depend on a network of interacting genes and proteins, including transcriptional activators such as CLOCK, NPAS2, and ARNTL (BMAL1), which induce transcription of the clock genes Period ( Per1 , Per2 , and Per3 ) and Cryptochrome ( Cry1 and Cry2 ). Human salivary cortisol and melatonin follow a clear circadian rhythm as well. Disruption of the circadian rhythm and sleep-wake cycles are considered risk factors for a variety of health problems, especially hypertension and other cardiovascular and metabolic diseases. Here we put together practical methods for assessing circadian rhythms in adult subjects conducted by each individual. This method is non-invasive, inexpensive and provides a predictive profile of an individual’s circadian rhythm related to clock-controlled gene expression in buccal cells, salivary cortisol, salivary melatonin, and subject’s activity or sleep. Subjects are instructed on how to obtain buccal cells using swabs (Whatman OmniSwab) from the inside of their cheeks and collect saliva using salivettes (Sarstedt) every 4 hours starting at 6am, for 2 consecutive days. Subjects also wear actigraphy watches (Phillips Respironics) during the 2 days, to record their activity, light exposure and estimates of sleep times. To monitor adherence to correct time point collections, each subject is given an electronic vial called eCAP (Information Mediary Corp) that records the exact time the container is opened to place samples once collected. We demonstrate feasibility to extract up to 150ng/μl of RNA (Ambion RNAqueous-Micro Total RNA Isolation Kit) from buccal cells swabs. Salivary melatonin and cortisol are measured by radioimmunoassay (Buhlmann Lab) with melatonin peak levels ranging from 14 to 23 pg/ml and cortisol peak levels ranging from 10 to 24 ng/ml. We suggest that buccal cell expression of clock-controlled genes, salivary melatonin, salivary cortisol, and actigraphy data are valuable in providing reliable assessment of human circadian rhythm profiles under a variety of conditions.

scholarly journals Salivary Cortisol Patterns in People Living With Dementia

2021 ◽  
Vol 5 (Supplement_1) ◽  
pp. 437-437
Author(s):  
Fanghong Dong ◽  
Liming Huang ◽  
Subhash Aryal ◽  
G Adriana Perez ◽  
Nancy Hodgson ◽  
...  
Keyword(s):  
Older Adults ◽  
Circadian Rhythm ◽  
Salivary Cortisol ◽  
Cortisol Awakening Response ◽  
Circadian Pattern ◽  
Clinical Dementia Rating ◽  
Diurnal Cortisol ◽  
The Mean ◽  
Cortisol Levels

Abstract Salivary cortisol has a well-documented circadian pattern in older adults. Yet, the pattern of salivary cortisol in persons living with dementia (PLWD) due to circadian rhythm disturbances is unknown. This study examined diurnal salivary cortisol patterns in 176 PLWD (mean age 73.6±8.8, 33.3% male, clinical dementia rating >=0.5) by collecting saliva at waking (AM1), 30 minutes after waking (AM2) and bedtime (PM) over two consecutive days. Cortisol awakening response (CAR) was calculated as the change between AM2 and AM1 cortisol levels. The mean baseline salivary cortisol levels (ug/dl) were 0.35 (SD:0.3) at AM1, 0.40 (SD:0.39) at AM2, and 0.19 (SD:0.4) at PM. On average, cortisol levels decreased from morning to evening, with 58% exhibiting a positive CAR (mean 0.05; SD:0.34). There were no significant associations between cortisol levels with age, sex, obesity, and comorbidities. The findings demonstrated that diurnal cortisol rhythms are maintained in PLWD with a flattened CAR.

scholarly journals Relationships Between Salivary Cortisol Slope and Neuropsychiatric Symptoms in Persons Living With Dementia

2021 ◽  
Vol 5 (Supplement_1) ◽  
pp. 437-437
Author(s):  
Fanghong Dong ◽  
G Adriana Perez ◽  
Nancy Hodgson ◽  
Yeji Hwang
Keyword(s):  
Data Analysis ◽  
Health Outcomes ◽  
Salivary Cortisol ◽  
Neuropsychiatric Symptoms ◽  
Secondary Data ◽  
Anxiety Symptoms ◽  
Poor Health ◽  
Future Research ◽  
Diurnal Cortisol ◽  
The Difference

Abstract While a flatter diurnal cortisol slope has been related to poor health outcomes in healthy populations, little is known about this relationship in persons living with dementia (PLWD). The purpose of this study was to examine the association between diurnalcortisol slope and neuropsychiatric symptoms in PLWD. Secondary data analysis was conducted using baseline data from the Healthy Patterns Study (N=168). Diurnal cortisol slope was calculated using the difference between changes in salivary cortisol from 30 minutes after awakening to bedtime. Spearman rho coefficients were used. Flatter cortisol slope was associated with the presence of symptoms of agitation (r=-0.191, p=0.013) and disinhibition (r=-0.168, p=0.03). Steeper cortisol slope was related to a more severe level of anxiety symptoms (r=0.36, p=0.009) and higher frequency of insomnia (r=0.292, p=0.011). We found that cortisol slope was associated with neuropsychiatric symptoms in PLWD. Future research is needed to examine the mechanisms underlying the relationships.

scholarly journals Use of white light therapy in treatment of non-motor symptoms in Parkinson’s disease

2021 ◽  
Vol 11 (9) ◽  
pp. 298-303
Author(s):  
Wanesa Góralczyk ◽  
Eryk Mikos ◽  
Karol Kanon
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Circadian Rhythm ◽  
White Light ◽  
Neurodegenerative Disorder ◽  
Light Exposure ◽  
Light Therapy ◽  
Time Of Day ◽  
Motor Symptoms ◽  
Non Motor Symptoms

Introduction. Parkinson’s disease (PD) is a progressive neurodegenerative disorder, associated with selective loss of neurons in the substantia nigra. Parkinson’s disease revealed by motor and non-motor symptoms. Alternative therapies for cure non-motor symptoms are searched. One of them can be white light therapy, which is based on taking samples of light specified illuminance, time of day, period and head-to-light distance.   Brief description of the state of knowledge. The purpose of white light therapy is stabilization of the circadian melatonin secretion and improvement of circadian rhythmicity. Morning white light exposure allows to accelerate the circadian rhythm and is effective in cure of depression disorders. In turn evening light exposure is used to delayed the circadian rhythm and treat early awaking insomnia. The effectiveness of treatment by white light therapy other neurological and neuropsychiatric disease as depression or sleep disorder is well-documented.   Conclusions. White Light Therapy is a safe, easy to use, and inexpensive non-pharmacological treatment option with rare side effects. Research shows that light has a significant therapeutic effect on a broad spectrum of symptoms, such as tremor, bradykinesia, rigidity, insomnia. However more evidence is needed to define specific dose of light for treatment non-motor symptoms Parkinson’s disease and the regime of its intake (length of irradiation, time of day, distance between the head and the light source).

Lack of Adult-Type Salivary Cortisol Circadian Rhythm in Hospitalized Preterm Infants

2005 ◽  
Vol 64 (1) ◽  
pp. 20-27 ◽  
Author(s):  
Susan Kidd ◽  
Paula Midgley ◽  
Mary Nicol ◽  
John Smith ◽  
Neil McIntosh
Keyword(s):  
Circadian Rhythm ◽  
Preterm Infants ◽  
Salivary Cortisol ◽  
Adult Type

Pineal response types in the frog's brain under white light exposure

1979 ◽  
Vol 36 (1) ◽  
Author(s):  
J. Cadusseau ◽  
F. Gaillard ◽  
G. Galand
Keyword(s):  
White Light ◽  
Light Exposure

Application of melatonin for prevention and treatment of circadian rhythm disorders

2021 ◽  
Vol 19 (2) ◽  
pp. 34-38
Author(s):  
A. S. SAMOYLOV ◽  
◽  
N. V. RYLOVA ◽  
A. V. ZHOLINSKIY ◽  
I. V. BOLSHAKOV ◽  
...  
Keyword(s):  
Circadian Rhythm ◽  
Side Effects ◽  
Light Exposure ◽  
The Body ◽  
Optimal Dosage ◽  
Vital Activity ◽  
Time Zone ◽  
Prevention And Treatment ◽  
Time Of Administration ◽  
Circadian Rhythm Disorders

The article presents data from the Russian and foreign literature of the properties of melatonin, its role in the vital activity of the body and the regulation of circadian rhythms. The features of using the drug in desynchronosis, the optimal dosage and time of administration, as well as the possibility of its use in combination with non-pharmacological treatment methods are discussed. These methods include dosed light exposure and exercise. Additionally, new studies are considered, indicating the beneficial effect of melatonin and its agonists on the immune, cardiovascular, endocrine and nervous systems. Based on the collected data, it is asserted that melatonin can significantly accelerate the process of adaptation to a new time zone without the development of side effects. Therefore, this drug is the most effective and safe treatment for desynchronosis. It is also important to note that the study of the multifaceted effects of melatonin on body functions opens up great prospects in the treatment of many diseases.

scholarly journals Light, Alertness, and Alerting Effects of White Light: A Literature Overview

2018 ◽  
Vol 33 (6) ◽  
pp. 589-601 ◽  
Author(s):  
Renske Lok ◽  
Karin C. H. J. Smolders ◽  
Domien G. M. Beersma ◽  
Yvonne A. W. de Kort
Keyword(s):  
White Light ◽  
Light Exposure ◽  
Neural Mechanisms ◽  
Dependent Manner ◽  
Experimental Paradigm ◽  
Research Paradigms ◽  
Lighting Conditions ◽  
Literature Overview ◽  
Dose Dependent ◽  
As Effects

Light is known to elicit non–image-forming responses, such as effects on alertness. This has been reported especially during light exposure at night. Nighttime results might not be translatable to the day. This article aims to provide an overview of (1) neural mechanisms regulating alertness, (2) ways of measuring and quantifying alertness, and (3) the current literature specifically regarding effects of different intensities of white light on various measures and correlates of alertness during the daytime. In general, the present literature provides inconclusive results on alerting effects of the intensity of white light during daytime, particularly for objective measures and correlates of alertness. However, the various research paradigms employed in earlier studies differed substantially, and most studies tested only a limited set of lighting conditions. Therefore, the alerting potential of exposure to more intense white light should be investigated in a systematic, dose-dependent manner with multiple correlates of alertness and within one experimental paradigm over the course of day.

scholarly journals Photoradiation models for the clinical ex vivo treatment of autologous bone marrow grafts

Blood ◽  
1987 ◽  
Vol 70 (2) ◽  
pp. 484-489
Author(s):  
J Atzpodien ◽  
SC Gulati ◽  
A Strife ◽  
BD Clarkson
Keyword(s):  
Bone Marrow ◽  
Tumor Cells ◽  
White Light ◽  
Ex Vivo ◽  
Light Exposure ◽  
B Cell Lymphoma ◽  
Autologous Bone Marrow ◽  
Neoplastic Cells ◽  
Drug Concentrations ◽  
Autologous Bone

To assess the potential of photoradiation therapy for the in vitro purging of residual tumor cells from autologous bone marrow (BM) transplants, we studied normal marrow and tumor cell clonogenicity in response to different light-activated compounds by using the fluorescent dyes dihematoporphyrin ether (DHE) and merocyanine-540 (MC- 540). After photoradiation of cells with white light, both DHE and MC- 540 showed high cytocidal activity toward lymphoid and myeloid neoplastic cells but had a significantly lesser effect on normal granulocyte-macrophage (CFU-GM), erythroid (BFU-E), and mixed colony- forming (CFU-GEMM) progenitor cells. Acute promyelocytic leukemia (HL- 60), non-B, non-T, CALLA-positive acute lymphoblastic leukemia (Reh), and diffuse histocytic B cell lymphoma (SK-DHL-2) cell lines were exposed to different drug concentrations in combination with white light at a constant illumination rate of 50,000 lux. With DHE doses varying from 2.0 to 2.5 micrograms/mL and MC-540 concentrations of 15 to 20 micrograms/mL, clonogenic tumor cells could be reduced by more than 4 logs when treated alone or in mixtures with normal irradiated human marrow cells. However, preferential cytotoxicity towards neoplastic cells was highly dependent on the mode of light activation. MC-540 had no substantial effect on malignant lymphoid (SK-DHL-2) and myeloid (HL-60) cells and on normal marrow myeloid (CFU-GM) precursors when drug incubation was performed in the dark and followed by light exposure of washed cells. Equal doses of MC-540 (15 to 20 micrograms/mL) could preferentially eliminate tumor cells under conditions of simultaneous light and drug treatment (30 minutes at 37 degrees C). When using DHE (2.5 micrograms/mL), 29.3%, 46.8%, and 27.5% of normal marrow CFU-GM, BFU-E, and CFU-GEMM, respectively, were spared after sequential drug and light exposure of cells, whereas simultaneous treatment reduced both normal (CFU-GM) and neoplastic cells below the limits of detection. In summary, our results indicate the usefulness of various photoradiation models for the ex vivo treatment of leukemic and lymphomatous bone marrow autografts.

Sign in / Sign up

Export Citation Format

Share Document